Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | -137 | 137 | 20 | 8 |
| Accounts receivable | 56 | -9 | -93 | 5 | -4 |
| Other Working Capital | 73 | -862 | 366 | -98 | 90 |
| Other Operating Activity | -1,100 | -127 | -1,400 | -124 | -289 |
| Operating Cash Flow | $-971 | $-1,135 | $-988 | $-198 | $-195 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 142 | 0 | 0 | 0 |
| Investing Cash Flow | $N/A | $142 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 112 | N/A | N/A | N/A |
| Debt Repayment | 0 | -74 | -25 | -25 | -12 |
| Common Stock Issued | N/A | 1,918 | N/A | N/A | N/A |
| Other Financing Activity | 2,986 | -295 | 1,680 | 0 | 0 |
| Financing Cash Flow | $2,986 | $1,661 | $1,656 | $-25 | $-12 |
| Beginning Cash Position | 1,381 | 713 | 45 | 268 | 475 |
| End Cash Position | 3,397 | 1,381 | 713 | 45 | 268 |
| Net Cash Flow | $2,015 | $669 | $667 | $-223 | $-207 |
| Free Cash Flow | |||||
| Operating Cash Flow | -971 | -1,135 | -988 | -198 | -195 |
| Free Cash Flow | -971 | -1,135 | -988 | -198 | -195 |